These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33802603)

  • 1. Inactivation of SARS-CoV-2 through Treatment with the Mouth Rinsing Solutions ViruProX
    Koch-Heier J; Hoffmann H; Schindler M; Lussi A; Planz O
    Microorganisms; 2021 Mar; 9(3):. PubMed ID: 33802603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virucidal activity of oral care products against SARS-CoV-2
    Komine A; Yamaguchi E; Okamoto N; Yamamoto K
    J Oral Maxillofac Surg Med Pathol; 2021 Jul; 33(4):475-477. PubMed ID: 33643836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary SARS-CoV-2 load reduction with mouthwash use: A randomized pilot clinical trial.
    Eduardo FP; Corrêa L; Heller D; Daep CA; Benitez C; Malheiros Z; Stewart B; Ryan M; Machado CM; Hamerschlak N; Rebello Pinho JR; Bezinelli LM
    Heliyon; 2021 Jun; 7(6):e07346. PubMed ID: 34189331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
    Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
    J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preprocedural mouth rinses for preventing transmission of infectious diseases through aerosols in dental healthcare providers.
    Kumbargere Nagraj S; Eachempati P; Paisi M; Nasser M; Sivaramakrishnan G; Francis T; Verbeek JH
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD013826. PubMed ID: 35994295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.
    Seneviratne CJ; Balan P; Ko KKK; Udawatte NS; Lai D; Ng DHL; Venkatachalam I; Lim KS; Ling ML; Oon L; Goh BT; Sim XYJ
    Infection; 2021 Apr; 49(2):305-311. PubMed ID: 33315181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouth rinses efficacy on salivary SARS-CoV-2 viral load: A randomized clinical trial.
    Alzahrani MM; Bamashmous S; Alkharobi H; Alghamdi A; Alharbi RH; Hassan AM; Darwish M; Bukhari A; Mahmoud AB; Alfaleh MA; Mirza AA; Abuzenadah AM; Abujamel TS; Hashem AM
    J Med Virol; 2023 Jan; 95(1):e28412. PubMed ID: 36527332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virucidal Activity of Different Mouthwashes Using a Novel Biochemical Assay.
    Rodríguez-Casanovas HJ; la Rosa M; Bello-Lemus Y; Rasperini G; Acosta-Hoyos AJ
    Healthcare (Basel); 2021 Dec; 10(1):. PubMed ID: 35052227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study.
    Perussolo J; Teh MT; Gkranias N; Tiberi S; Petrie A; Cutino-Moguel MT; Donos N
    Sci Rep; 2023 Aug; 13(1):12647. PubMed ID: 37542087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of a preprocedural mouthrinse containing cetylpyridinium chloride in reducing bacteria in the dental office.
    Feres M; Figueiredo LC; Faveri M; Stewart B; de Vizio W
    J Am Dent Assoc; 2010 Apr; 141(4):415-22. PubMed ID: 20354090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preprocedural mouthwashes for infection control in dentistry-an update.
    Weber J; Bonn EL; Auer DL; Kirschneck C; Buchalla W; Scholz KJ; Cieplik F
    Clin Oral Investig; 2023 Jun; 27(Suppl 1):33-44. PubMed ID: 37079156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of mouth rinses against COVID-19: a systematic review and network meta-analysis.
    Lin SY; Sun JS; Hung MC; Chang JZ
    J Hosp Infect; 2023 Sep; 139():175-191. PubMed ID: 37419189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study.
    Bezinelli LM; Corrêa L; Beyerstedt S; Franco ML; Rangel ÉB; Benítez CG; Hamerschlak N; Pinho JRR; Heller D; Eduardo FP
    PeerJ; 2023; 11():e15080. PubMed ID: 38130922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility and efficacy of a CPC- and CHX-based antiviral mouthwash for the elimination of SARS-CoV-2 from the saliva: A randomized, double-blind, controlled clinical trial.
    Brunello G; Wolf V; Kerberger R; Bernhard M; Lübke N; Becker J; Schwarz-Herzke B; Timm J; Becker K
    J Clin Periodontol; 2024 Feb; 51(2):158-166. PubMed ID: 38058254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is hydrogen peroxide an effective mouthwash for reducing the viral load of SARS-CoV-2 in dental clinics?
    Burgos-Ramos E; Urbieta IR; Rodríguez D
    Saudi Dent J; 2022 Mar; 34(3):237-242. PubMed ID: 35136326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of amine fluoride/stannous fluoride in the suppression of morning breath odour.
    Quirynen M; Avontroodt P; Soers C; Zhao H; Pauwels M; Coucke W; van Steenberghe D
    J Clin Periodontol; 2002 Oct; 29(10):944-54. PubMed ID: 12445227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of mouthwashes against COVID-19 in dentistry.
    Vergara-Buenaventura A; Castro-Ruiz C
    Br J Oral Maxillofac Surg; 2020 Oct; 58(8):924-927. PubMed ID: 32859459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2.
    Okamoto N; Saito A; Okabayashi T; Komine A
    J Oral Maxillofac Surg Med Pathol; 2022 Nov; 34(6):800-804. PubMed ID: 35441076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mouthrinses in reducing oral SARS-COV-2 load: a review.
    Pannuti CM; Reis INRD; Souza NV; Souto MLS; Silva CGB; Bezinelli LM; Machado CM; Romito GA; Villar CC
    Braz Oral Res; 2023; 37():e038. PubMed ID: 37132726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of de novo plaque growth by a new 0.03 % chlorhexidine mouth rinse formulation applying a non-brushing model: a randomized, double blind clinical trial.
    Mor-Reinoso C; Pascual A; Nart J; Quirynen M
    Clin Oral Investig; 2016 Sep; 20(7):1459-67. PubMed ID: 26475499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.